Estradiol valerate + testosterone undecanoate
Estradiol valerate + testosterone undecanoate has been studied in 2 papers since 2012: 2 trials in people. The newest paper, Oct 25, 2012: “Effect of estrogen and testosterone replacement therapy on cognitive fatigue”.
2 papers study it2 findingsUpdated
“Treatment-dependent and hormone-specific effects on serum metabolites were observed, ranging between 69% reduction and 184% increase”
- 1 lab in 1 country
- Human trial2
What did studies of Estradiol valerate + testosterone undecanoate find?
1Studies of Estradiol valerate + testosterone undecanoate measured 1 outcome; the most studied are cognitive fatigue (1 study).
Cognitive fatigue
no changein humans1
1 study
Cognitive fatigue
no changein humans1
Estradiol valerate + testosterone undecanoate has no effect on cognitive fatigue in humans.
“Treatment with testosterone + estrogen had no significant effect on cognitive fatigue”
Human trialsurgically induced menopauseestradiol valerate in combination with testosterone undecanoate24 weeksfemalesn = 50
Effect of estrogen and testosterone replacement therapy on cognitive fatigue
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
What is Estradiol valerate + testosterone undecanoate linked with?
1Studies link Estradiol valerate + testosterone undecanoate with 1 measure, most often serum metabolites (1 study).
Serum metabolites
mixedin humans1
1 study
Serum metabolites
mixedin humans1
Estradiol valerate + testosterone undecanoate is associated with serum metabolites in humans (ranging between 69% reduction and 184% increase).
“Treatment-dependent and hormone-specific effects on serum metabolites were observed, ranging between 69% reduction and 184% increase”
Human trialserum3 monthsfemalesn = 60
Effects of oestrogen and testosterone therapy on serum metabolites in postmenopausal women
Clinical endocrinology